Europe Proteomics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Europe Proteomics Companies and the market is Segmented by Products and Services (Instrumentation Technology, Reagents, and Software and Services), Applications (Clinical Diagnostics, Drug Discovery, and Other Applications), and Geography (Germany, UK, France, Italy, Spain, and Rest of Europe). The report offers the value (in USD million) for the above segments.

Europe Proteomics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Europe Proteomics Market Size

View Global Report
Europe Proteomics Market is poised to grow at a CAGR of 12.4 % by 2028. Europe Proteomics Market is driven by  rising demand for personalized medicine, increasing research and expenditure, and government funding for proteomics.
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 12.40 %

Major Players

Europe Proteomics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Europe Proteomics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Europe Proteomics Market Analysis

The Europe Proteomics Market is expected to register a CAGR of 12.4% during the forecast period.

The COVID-19 pandemic turned the spotlight on proteomic studies, and thus, it is expected to drive the studied market growth during the present crisis. According to an article published in the International Journal of Molecular Sciences in March 2022, it has been observed that omics-based technologies were largely adopted during the COVID-19 pandemic. The omic technology could be applied at every level of application, from the detection of mutations, methods of diagnosis or monitoring, drug target discovery, and vaccine generation, to the basic definition of the pathophysiological processes and the biochemical mechanisms behind the infection and spread of SARS-CoV-2. Proteomics aids in the identification of novel biomarkers of the SARS-CoV-2 virus and thus provides effective opportunities for point-of-care clinical healthcare delivery in the most cost-effective manner. Thus, the wide application of proteomics in developing therapeutics for coronavirus has impacted market growth during a pandemic. Moreover, the rising adoption of proteomics technology by pharmaceutical companies and the increasing demand for personalized medicines also increased market growth and are expected to continue over the forecast period.

Factors such as the rising demand for personalized medicine, increasing research and expenditure, and government funding for proteomics, as well as technological advancements, are boosting the market's growth.

Proteomics has received great attention over the last decade, particularly in the fields of diagnosis, drug research, and drug development. It has various applications, ranging from the identification of proteins to the purification and separation of the proteins to study their nature and properties. It has numerous applications in identifying protein-related disorders or diseases in the body.Thus, it is evolving into an important tool in the field of life sciences.

Furthermore, increasing demand for personalized medicine in Europe, along with the presence of key market players such as Merck KGaA, is expected to boost regional growth. Also, positive support from the local authorities in Europe and initiatives by research organizations to advance proteomics technologies such as chemoproteomics and spectrometry are expected to further fuel market growth. For example, Biognosys, a Swiss company, will launch Spectronaut 16 and present major scientific and technological advances of its proprietary proteomics research services at the American Society for Mass Spectrometry (ASMS) Annual Conference in May 2022.

Similarly, in February 2021, the international metaproteomics community launched the Metaproteomics Initiative to promote the dissemination of metaproteomics fundamentals, advancements, and applications through collaborative networking in microbiome research.

Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. The high cost of instruments, on the other hand, is likely to slow the growth of the proteomics market in Europe over the next few years.

Europe Proteomics Industry Overview

The European proteomics market is moderately consolidated and consists of a few major players. Companies like Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Merck KGaA, Promega Corporation, Thermo Fisher Scientific Inc., and Waters Corporation are key players, among others. The companies are involved in various strategies, such as new product launches and investments in research and development activities, to sustain themselves in the highly competitive environment.

Europe Proteomics Market Leaders

  1. Agilent Technologies, Inc.

  2. Bio-Rad Laboratories, Inc.

  3. Thermo Fisher Scientific, Inc.

  4. Merck KGaA

  5. Promega Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Picture1.png
Need More Details on Market Players and Competiters?
Download PDF

Europe Proteomics Market News

  • August 2022: Proteome Sciences, a European-based company, completed the next milestone towards the launch of "single cell proteomics" services.
  • March 2022: Biognosys, a Switzerland-based company, launched its expanded suite of proteomics platforms, TrueDiscovery, TrueTarget, and TrueSignature, to provide an integrated suite of research services to pharmaceutical and diagnostics customers with deep biological insights across the entire research and development pipeline, from early-stage discovery to clinical settings. Through this launch, the company develops and runs customizable precision proteomics biomarker panels.

Europe Proteomics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Personalized Medicine
    • 4.2.2 Increasing R&D Expenditure and Government Funding for Proteomics
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Products and Services
    • 5.1.1 Instrumentation Technology
    • 5.1.1.1 Spectroscopy
    • 5.1.1.2 Chromatography
    • 5.1.1.3 Electrophoresis
    • 5.1.1.4 Protein Microarrays
    • 5.1.1.5 X-ray Crystallography
    • 5.1.1.6 Other Instrumentation Technologies
    • 5.1.2 Reagents
    • 5.1.3 Software and Services
  • 5.2 By Application
    • 5.2.1 Clinical Diagnostics
    • 5.2.2 Drug Discovery
    • 5.2.3 Other Applications
  • 5.3 Geography
    • 5.3.1 Germany
    • 5.3.2 United Kingdom
    • 5.3.3 France
    • 5.3.4 Italy
    • 5.3.5 Spain
    • 5.3.6 Rest of Europe

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies Inc.
    • 6.1.2 Bio-Rad Laboratories Inc.
    • 6.1.3 Thermo Fisher Scientific Inc.
    • 6.1.4 Danaher Corporation
    • 6.1.5 Waters Corporation
    • 6.1.6 Promega Corporation
    • 6.1.7 Merck KGaA
    • 6.1.8 Bruker Corporation
    • 6.1.9 DiaSorin S.p.A (Luminex Corporation)
    • 6.1.10 PerkinElmer Inc.
    • 6.1.11 Sengenics
    • 6.1.12 Horiba Ltd
    • 6.1.13 Creative Proteomics
    • 6.1.14 Becton, Dickinson and Company
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Proteomics Industry Segmentation

As per the scope of the report, proteomics is the study of protein structure and function. At the cellular level, proteomics deals with topics, such as which proteins are expressed, when and where they are expressed, what their structures are in both active and inactive states, what roles they play in the life of the cell, and how they interact with other proteins and molecules. The Europe proteomics market is divided into three sections: products and services (instrumentation technology (spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, and other instrumentation technologies), reagents, and software and services), application (clinical diagnostics, drug discovery, and other applications), and geography (Germany, United Kingdom, France, Italy, Spain, and the Rest of Europe). The report offers the value (in USD million) for the above segments.

By Products and Services Instrumentation Technology Spectroscopy
Chromatography
Electrophoresis
Protein Microarrays
X-ray Crystallography
Other Instrumentation Technologies
Reagents
Software and Services
By Application Clinical Diagnostics
Drug Discovery
Other Applications
Geography Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Need A Different Region or Segment?
Customize Now

Europe Proteomics Market Research FAQs

What is the current Europe Proteomics Market size?

The Europe Proteomics Market is projected to register a CAGR of 12.4% during the forecast period (2025-2030)

Who are the key players in Europe Proteomics Market?

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck KGaA and Promega Corporation are the major companies operating in the Europe Proteomics Market.

What years does this Europe Proteomics Market cover?

The report covers the Europe Proteomics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Proteomics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Brazil Respiratory Devices Industry Report

Statistics for the 2025 Europe Proteomics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Proteomics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.